| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919683 | Radiotherapy and Oncology | 2011 | 6 Pages |
Abstract
Premature discontinuation of the trial did not allow us to draw firm conclusions. However, there was no suggestion that concurrent re-irradiation, fluorouracil and hydroxyurea improved OS compared to methotrexate alone in patients treated with palliative intent for a recurrent or second primary HNSCC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jacques Tortochaux, Yungan Tao, Elodie Tournay, Michel Lapeyre, Francois Lesaunier, Etienne Bardet, François Janot, Antoine Lusinchi, Ellen Benhamou, Patrick Bontemps, Philippe Maingon, Gilles Calais, Nicolas Daly-Schveitzer, Pierre Verrelle,